Indicator Ventures
VC Fund
New York, United States
Indicator Ventures is an early stage venture capital firm investing in extraordinary founders building technology that makes work, life and wealth building easier and more accessible. We are a lean and collaborative team of lead investors at the earliest stages with over 70 portfolio companies across 3 successful funds. We are most interested ininvesting in companies building software infrastructure to remove everyday friction points and companies ensuring user accessibility in the worlds largest industries.
- Total investments:
- 126
- Last investment:
- Lead investor:
- 28%
- Fund size:
- $47M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Indicator Ventures invests in
Stages Indicator Ventures invests in
Countries Indicator Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 11 contacts → | |||
Investment Focus
Industry
- Software 23 (18%)
- Health Care 13 (10%)
- FinTech 8 (6%)
- Apps 7 (6%)
- SaaS 7 (6%)
Stage
- Seed 51 (40%)
- Series A 22 (17%)
- Funding Round 9 (7%)
- Pre-Seed 8 (6%)
- Venture - Series Unknown 7 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Aditya Pandyaram
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
Baiyin Murphy
General Partner
|
General Partner | Total investments: 3 | Find email | |
Baiyin Murphy
General Partner
|
General Partner | Total investments: 0 | Find email | |
Ben Luntz
Co-Founder & Partner Emeritus
|
Co-Founder & Partner Emeritus | Total investments: 0 | Find email | |
Daniel Lieberman
Venture Partner
|
Venture Partner | Total investments: 1 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Hike Medical develops a healthcare technology platform that supports the workflow for durable medical equipment, prosthetics and orthotics, and podiatry providers. Its platform combines Hike Clinical for patient evaluations, documentation, 3D scanning, and device ordering with Hike Intelligence for referral processing, eligibility checks,documentation management, and payer-related workflows. The company also operates an in-house laboratory that uses 3D printing to produce custom orthotics and other devices, including diabetic shoes and inserts. Its system connects clinical, administrative, ordering, and fabrication processes within a single workflow, helping providers manage patient referrals through device fulfillment. | $22.5M / Series A / Aug 25, 2026 | ||
| EDGE Markets provides financial infrastructure designed for trading, gaming, and other alternative financial markets, supporting both institutional and consumer participants. The company offers banking, payment, settlement, and capital movement solutions tailored for environments that require high-frequency, real-time transactions. Its platformincludes products such as EDGE Connect, a private payments and settlement network, and EDGE Pro, a banking platform for market makers and institutional investors operating in regulated markets. EDGE Markets also develops specialized debit and banking services intended to facilitate deposits, withdrawals, liquidity management, and transaction tracking while incorporating compliance and responsible-use controls. Through its integrated financial infrastructure, the company aims to improve the efficiency of payments, settlements, and capital flows across gaming, prediction, crypto, and trading ecosystems. | $29.2M / Series A / Jun 08, 2026 | ||
| Beacon Biosignals is a neurotechnology company focused on bringing precision neuroscience into clinical trials and treatments for brain- and sleep-related disorders. The company’s core offering includes an FDA-cleared wearable device (the Waveband headband) that captures high-fidelity EEG during sleep and wake states, combined with an AI-drivenanalytics platform that processes millions of hours of neural data to extract biomarkers of brain function. Its end-to-end solution supports pharmaceutical and biotech clients by providing tools for patient stratification, dose-response monitoring, and early-stage disease progression, enabling trials to be more precise and efficient. | $11M / Series B / Apr 06, 2026 | ||
| Beacon Biosignals is a neurotechnology company focused on bringing precision neuroscience into clinical trials and treatments for brain- and sleep-related disorders. The company’s core offering includes an FDA-cleared wearable device (the Waveband headband) that captures high-fidelity EEG during sleep and wake states, combined with an AI-drivenanalytics platform that processes millions of hours of neural data to extract biomarkers of brain function. Its end-to-end solution supports pharmaceutical and biotech clients by providing tools for patient stratification, dose-response monitoring, and early-stage disease progression, enabling trials to be more precise and efficient. | $86M / Series B / Nov 13, 2025 | ||
| Audioshake makes sound more usable for both humans and machines by separating sound into its component parts. Used by some the world's largest media, entertainment, and tech companies, AudioShake is used in audio editing workflows, Voice AI, and multimodal training. | $14M / Series A / Oct 01, 2025 | ||
| Hike Medical develops a healthcare technology platform that supports the workflow for durable medical equipment, prosthetics and orthotics, and podiatry providers. Its platform combines Hike Clinical for patient evaluations, documentation, 3D scanning, and device ordering with Hike Intelligence for referral processing, eligibility checks,documentation management, and payer-related workflows. The company also operates an in-house laboratory that uses 3D printing to produce custom orthotics and other devices, including diabetic shoes and inserts. Its system connects clinical, administrative, ordering, and fabrication processes within a single workflow, helping providers manage patient referrals through device fulfillment. | $5M / Seed / Jul 07, 2025 | ||
| Fueling Small Businesses Across America With Industry-Tailored Credit Cards. | $17M / Series A / May 20, 2025 | ||
| We make it easy for you to file your claim and secure your compensation from corporations that violated your rights. | $3.6M / Seed / Apr 29, 2025 | ||
| EDGE Markets provides financial infrastructure designed for trading, gaming, and other alternative financial markets, supporting both institutional and consumer participants. The company offers banking, payment, settlement, and capital movement solutions tailored for environments that require high-frequency, real-time transactions. Its platformincludes products such as EDGE Connect, a private payments and settlement network, and EDGE Pro, a banking platform for market makers and institutional investors operating in regulated markets. EDGE Markets also develops specialized debit and banking services intended to facilitate deposits, withdrawals, liquidity management, and transaction tracking while incorporating compliance and responsible-use controls. Through its integrated financial infrastructure, the company aims to improve the efficiency of payments, settlements, and capital flows across gaming, prediction, crypto, and trading ecosystems. | $17.2M / Seed / Mar 24, 2025 | ||
| EDGE Markets provides financial infrastructure designed for trading, gaming, and other alternative financial markets, supporting both institutional and consumer participants. The company offers banking, payment, settlement, and capital movement solutions tailored for environments that require high-frequency, real-time transactions. Its platformincludes products such as EDGE Connect, a private payments and settlement network, and EDGE Pro, a banking platform for market makers and institutional investors operating in regulated markets. EDGE Markets also develops specialized debit and banking services intended to facilitate deposits, withdrawals, liquidity management, and transaction tracking while incorporating compliance and responsible-use controls. Through its integrated financial infrastructure, the company aims to improve the efficiency of payments, settlements, and capital flows across gaming, prediction, crypto, and trading ecosystems. | Seed / Dec 01, 2024 | ||
| See all 126 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Indicator Ventures invest in?
Indicator Ventures invests primarily in Software, Health Care and FinTech startups, most often at Seed and Series A stage. Most of the 126 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Indicator Ventures?
Public channels for Indicator Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Indicator Ventures?
The team at Indicator Ventures includes Aditya Pandyaram (Venture Partner), Baiyin Murphy (General Partner) and Baiyin Murphy (General Partner), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
